LDV Capital — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Austin, US
Matthew Udvari(Executive Officer, Director)Chen Zhang(Executive Officer, Director)
Board seatEvan Nisselson· per SEC Form D · $4.5M raise · filed Jan 2024
VitVio builds Vetro, a surgical operations platform that uses 3D spatial intelligence and ambient sensing to track perioperative workflows in real time, automatically generate operative notes, identify surgical trays, and write data back to hospital EHR systems like Epic and Cerner.
AI & Machine LearningHealthtechMedical DevicesWilmington, US
Aleks Pajewski(Founder)inKendall Clifton Weisel(Executive Officer, Director)Maksymilian Jerzy Kozarzewski(Executive Officer, Director)
Board seatEvan Nisselson· per SEC Form D
Co-investorsBalnord Sp. z o.o.
Fieldstone Bio builds engineered biosensors combined with hyperspectral imaging to detect and map critical minerals such as gold, copper, and arsenic in soil samples, cores, and tailings.
AI & Machine LearningBiotechDeep TechNew MaterialsAndover, US
Patrick Stone(Executive Officer, Director)inBrandon Fields(Director)in
BoardCalvin Chin(Director)in
Co-investorsThe E14 FundUbiquity Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.